马克·考文垂奖:PhotothermAA凝胶联合清创、抗生素及假体保留显著降低兔膝假体周围关节感染模型的假体生物膜负荷与软组织感染
在兔膝假体周围关节感染模型中,将抗生物膜PhotothermAA凝胶联合清创、抗生素及假体保留(DAIR)治疗,与单纯DAIR相比显著降低假体生物膜覆盖率和假体周围软组织培养菌量,且未观察到治疗相关组织坏死。
要点
- PhotothermAA联合DAIR组假体生物膜覆盖率1.8%,显著低于单纯DAIR组的81.0%(P < .0001)。
- 假体周围软组织培养菌量对数减少:假手术组1.6、DAIR组2.0、联合组5.6(P < .0001)。
- 治疗区域邻近组织大体组织学未见治疗相关坏死(P = .715)。
核心结论
- 在兔膝假体周围关节感染模型中,将抗生物膜PhotothermAA凝胶作为保留假体治疗的补充,可能对假体周围关节感染治疗有用。
研究设计与样本
- 研究纳入新西兰白兔21只,行膝关节切开、胫骨钛假体植入及胶囊闭合后接种生物发光金黄色葡萄球菌Xen36。
- 2周后 rabbits 接受假手术(n = 6)、DAIR(n = 6)或PhotothermAA联合DAIR(n = 9),2周后处死测量假体生物膜负荷、软组织感染和组织坏死。
主要发现
- 扫描电镜显示PhotothermAA联合DAIR组假体生物膜覆盖率1.8%,单纯DAIR组为81.0%(P < .0001)。
- 假体周围软组织培养菌量对数减少:假手术组1.6、DAIR组2.0、联合组5.6(P < .0001)。
- 治疗区域邻近组织大体组织学未见治疗相关坏死(P = .715)。
关键数值与推荐
- 扫描电镜假体生物膜覆盖率:PhotothermAA联合DAIR组1.8% vs 单纯DAIR组81.0%(P < .0001)。
- 假体周围软组织培养菌量对数减少:假手术组1.6、DAIR组2.0、联合组5.6(P < .0001)。
- 治疗区域邻近组织大体组织学坏死:P = .715。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic periprosthetic joint infection (PJI) is a major complication of total joint arthroplasty. The underlying pathogenesis often involves the formation of bacterial biofilm that protects the pathogen from both host immune responses and antibiotics. The gold standard treatment requires implant removal, a procedure that carries associated morbidity and mortality risks. Strategies to preserve the implant while treating PJI are desperately needed. Our group has developed an anti-biofilm treatment, PhotothermAA gel, which has shown complete eradication of 2-week-old mature biofilm in vitro. In this study, we tested the anti-biofilm efficacy and safety of PhotothermAA in vivo when combined with debridement, antibiotics and implant retention (DAIR) in a rabbit model of knee PJI. METHODS: New Zealand white rabbits (n = 21) underwent knee joint arthrotomy, titanium tibial implant insertion, and inoculation with Xen36 (bioluminescent Staphylococcus aureus) after capsule closure. At 2 weeks, rabbits underwent sham surgery (n = 6), DAIR (n = 6), or PhotothermAA with DAIR (n = 9) and were sacrificed 2 weeks later to measure implant biofilm burden, soft-tissue infection, and tissue necrosis. RESULTS: The combination of anti-biofilm PhotothermAA with DAIR significantly decreased implant biofilm coverage via scanning electron microscopy compared to DAIR alone (1.8 versus 81.0%; P < .0001). Periprosthetic soft-tissue cultures were significantly decreased in the PhotothermAA with DAIR treatment group (log reduction: Sham 1.6, DAIR 2.0, combination 5.6; P < .0001). Treatment-associated necrosis was absent via gross histology of tissue adjacent to the treatment area (P = .715). CONCLUSIONS: The addition of an anti-biofilm solution like PhotothermAA as a supplement to current treatments that allow implant retention may prove useful in PJI treatment.
引用
- Higuera-Rueda CA, Piuzzi NS, Milbrandt NB, et al. The Mark Coventry Award: PhotothermAA Gel Combined With Debridement, Antibiotics, and Implant Retention Significantly Decreases Implant Biofilm Burden and Soft-Tissue Infection in a Rabbit Model of Knee Periprosthetic Joint Infection. J Arthroplasty. 2024. PMID: 38401619. doi:10.1016/j.arth.2024.02.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。